Michael Ezekowitz MD

PubMed

• 1 citations
  Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient-Level Meta-Analysis From COMBINE AF.
  Linda S Johnson, Alexander P Benz, Ashkan Shoamanesh, John W Eikelboom, Michael Ezekowitz
  Journal of the American Heart Association. 2024-09-03
• 2 citations
  The ATHERO-AF Study: A Need to Optimize AF Management in an Environment of Medical Advancement.
  Michael D Ezekowitz, Ibrahim Alameh, Mohammed Kamareddine
  JACC. Advances. 2024-08-01
• 2 citations
  Emergency department visit for atrial fibrillation: sex differences in treatment and outcomes in the Global RE-LY AF Registry.
  Linda S Johnson, Yuxuan Jiang, Judy Luu, Isabelle C Van Gelder, Clare Atzema
  European Heart Journal. 2024-07-09

Journal Articles

• Original Investigation Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients with Atrial Fibrillation  
  Michael Ezekowitz, MD, ScienceDirect
• Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients with Atrial Fibrillation  
  Michael Ezekowitz, MD, JACC: Cardiovascular Imaging
• Choosing a Particular Oral Anticoagulant and Dose for Stroke Prevention in Individual Patients with Non-Valvular Atrial Fibrillation: Part 1  
  Jonathan L Halperin, Elaine M Hylek, Michael D Ezekowitz, James Aisenberg, European Heart Journal

Lectures

• Highlights in Anti-Coagulation 
  2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
• NOACs Post Cardioversion and Atrial Appendage Occlusion/Exclusion 
  2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
• Engage @ACC.19 Studio: Cardiology Contest 
  2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019